Skip to content

Culturally Adapted Family Intervention For Psychosis

Pilot Study of Culturaly Adapted Family Intervention for Psychosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02167347
Enrollment
36
Registered
2014-06-19
Start date
2012-02-29
Completion date
2014-12-31
Last updated
2015-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychosis

Keywords

CBT, Psychosis, cultural adaptation, Pakistan

Brief summary

Aim: To assess the feasibility of culturally adapted Family Intervention for Psychosis. Design: Randomized Control Trial Setting: psychiatric department of different hospitals Participants: A total of 36 caregivers of Psychosis patients will be randomized to psychological Intervention and treatment as usual arm. Intervention: Culturally Adapted Family Intervention for Psychosis Outcome measure: Positive and Negative syndrome scale (PANSS) Experience of care -giving inventory(ECI) Care Well-Being & Support(CWS)

Detailed description

The purpose of the study is to test the feasibility of culturally adaptive family intervention for Psychosis Primary Objective : * To test whether Pakistani families caring for someone with psychosis will engage with a model of family intervention which has been culturally adapted to meet their needs. * To evaluate the acceptability of the intervention to the families who receive it and to gather feedback regarding any changes that might improve the intervention. * To gain an impression of whether the intervention has the potential to address unmet psychological and social needs of the families and how this affects their levels of stress the investigators will conduct a feasibility pilot study to test whether Pakistani families offered the intervention will want to receive it. The Participants will be recruited from psychiatric department of different hospitals. They will be randomly divided into two groups; intervention group and treatment-as-usual group. A total of thirty six participants will be recruited in the pilot study and divided equally into two arms. This will ensure that, even after loss to follow-up, we will have at least 12 subjects per group for analysis (FDA guidance http://www.fda.gov/cder/guidance/5356fnl.pdf).Randomization will be carried out by the on offsite statistician. This will provide a reliable geographically remote service. For intervention group ten sessions of family intervention will be provided by trained research clinician during the period of three months. Relatives of Patients in the treatment as usual (TAU) group will be given details of intervention at the end of the study and interested families will be offered family intervention

Interventions

This 10 session Multi-modal Psychosocial Intervention will include a supportive component, an educational component, psychosocial component

Sponsors

University of Manchester
CollaboratorOTHER
Dow University of Health Sciences
CollaboratorOTHER
Abbasi Shaheed Hospital
CollaboratorOTHER
Pakistan Institute of Living and Learning
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Living with or with at least 10 hours per week face to face contact with an individual with psychosis who has a caring role. Plus the individual with psychosis themselves. 2. Individuals aged between 18-65. 3. Resident of Karachi. 4. Participant is able to give informed written consent.

Exclusion criteria

1. Severe drug or alcohol problem (i.e., those who fulfill the criteria for dependence according to ICD10 RDC). 2. Unstable residential arrangements such that the likelihood of being available for the duration of the trial is low. .

Design outcomes

Primary

MeasureTime frameDescription
Positive and Negative syndrome scale (PANSS)six monthsThe PANSS is a structured clinical interview consisting of 30 items designed to assess severity of symptoms over the past week on a 7-point scale.
Experience of Care-giving inventory(ECI)six monthsCommonly apply to persons who care for relative or friends With a serious mental illness
Carer Wel-Being & Support(CWS)six monthsA questionnaire for carers of people with a mental Health problem

Secondary

MeasureTime frameDescription
Short Explanatory Model Interviewsix monthsused to elicit beliefs of mental illness
Calgary Depression Scale for Schizophreniasix monthsThis is a nine-item scale developed by Addington et al. to assess depression in schizophrenia
Family Questionnaire(FQ)six monthsFind out the problem of caregiver for relative or friends With a serious mental illness.
Insight rating scalesix monthsAssesses Improvement in insight

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026